Cafepharma Today

January 28 2025 - Versant invests again in obesity, this time backing Helicore Biopharma
Versant invests again in obesity, this time backing Helicore Biopharma
Enhertu, with new FDA OK, set to supplant chemo in HER2-low breast cancer
Takeda regains home rights to phase 3-stage depression drug from Neurocrine
Stopwatch starts on reviews of GSK's long-acting asthma drug
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Moderna races to create norovirus vaccines
Beckers Hospital Review
Friday, January 24, 2025 - 11:43am
tags:
Moderna Therapeutics, vaccines, norovirus, mRNA-1403
Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug
Clinical Trials Arena
Friday, January 24, 2025 - 11:39am
tags:
Traws Pharma, tivoxavir marboxil, H5N1, clinical trials, bird flu
J&J is all in on tau-targeted Alzheimer’s candidates. Will the approach lead to more effective treatments?
Pharma Voice
Friday, January 24, 2025 - 11:32am
tags:
JNJ, anti-tau, Alzheimer's disease, R&D
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Fierce Pharma
Friday, January 24, 2025 - 11:30am
tags:
Merck, Eisai, clinical trials, Keytruda, Lenvima, gastroesophageal adenocarcinoma, GI cancers
ALX Oncology Shares Drop 15% Following Positive Phase 2
Yahoo/Guru Focus
Friday, January 24, 2025 - 11:26am
tags:
ALX Oncology, clinical trials, evorpacept, stomach cancer, gastroesophageal cancer
Neko Health raises $260m for its bid to transform healthcare
Pharmaphorum
Friday, January 24, 2025 - 11:22am
tags:
Neko Health, body scanning, Medtech, Daniel Ek
Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut
Fierce Biotech
Friday, January 24, 2025 - 11:21am
tags:
IPOs, Aardvark Therapeutics, Ascentage Pharma
Trump Administration Delays Funding To Cancer Research
Forbes
Thursday, January 23, 2025 - 11:13pm
tags:
Donald Trump, NIH, clinical trials, funding, cancer
AstraZeneca invests $570M to grow in Canada, plans to add 700 jobs
Fierce Biotech
Thursday, January 23, 2025 - 11:10pm
tags:
AstraZeneca, hirings, Canada
Here’s Why Beta Bionics Filing for an IPO Is a Big Deal
Medical Devices and Diagnostics Industry
Thursday, January 23, 2025 - 11:09pm
tags:
Medtech, Beta Bionics, IPOs, iLet Bionic Pancreas
Sacklers Up Their Offer to Settle Purdue Opioids Cases, With a New Condition
NY Times, NY
Thursday, January 23, 2025 - 11:07pm
tags:
Purdue Pharma, Sackler family, legal, opioids, opioid crisis
Masimo Snags a New CEO
Medical Devices and Diagnostics Industry
Thursday, January 23, 2025 - 11:05pm
tags:
Masimo, Medtech, Katie Szyman
Senate sets date to vet RFK Jr.’s nomination to lead HHS
BioPharma Dive
Thursday, January 23, 2025 - 11:04pm
tags:
Senate, HHS, Robert F Kennedy Jr.
AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender, buoyed by Skyrizi and Rinvoq spots
Fierce Pharma
Thursday, January 23, 2025 - 12:00pm
tags:
AbbVie, TV ads, DTC advertising, Skyrizi, Rinvoq
AI in medtech is taking off. Here are 4 trends to watch in 2025.
BioPharma Dive
Thursday, January 23, 2025 - 11:50am
tags:
artificial intelligence, AI, Medtech, FDA, hospitals
Merck KGaA says high asset prices call for prudent M&A approach
MSN/Reuters
Thursday, January 23, 2025 - 11:48am
tags:
Merck KGaA, Belén Garijo, M&A
AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B
BioSpace
Thursday, January 23, 2025 - 11:47am
tags:
AbbVie, Neomorph, molecular glue, molecular glue degraders
Intellia doses first subject in trial of NTLA-2002 for hereditary angioedema
Clinical Trials Arena
Thursday, January 23, 2025 - 11:46am
tags:
Intellia Therapeutics, NTLA-2002, clinical trials, HAE, hereditary angiodema
FDA Tacks Boxed Warning on Teva’s Copaxone, Other MS Drugs
BioSpace
Thursday, January 23, 2025 - 11:44am
tags:
Teva Pharmaceutical, black box, MS, multiple sclerosis, FDA, anaphylaxis
Maternal RSV vaccines found to cut infection risk
Axios
Thursday, January 23, 2025 - 11:42am
tags:
RSV, vaccines, Pfizer, Abrysvo, infants

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information